Identification of 14 novel CTNS mutations and characterization of seven splice site mutations associated with cystinosis
- PMID:12442267
- DOI: 10.1002/humu.10141
Identification of 14 novel CTNS mutations and characterization of seven splice site mutations associated with cystinosis
Abstract
Cystinosis is an autosomal recessive disorder characterized by intra-lysosomal accumulation of cystine. Three disease forms exist, infantile, juvenile, and ocular nonnephropathic cystinosis, delineated on the basis of severity of symptoms and age of onset. Mutations in the causative gene, CTNS, which encodes cystinosin, the seven transmembrane domain lysosomal cystine transporter, have been identified in all forms confirming their allelic status. By screening for mutations in the CTNS exons and promotor region, we report 14 novel mutations associated with cystinosis: 11 underlying infantile cystinosis, two juvenile cystinosis, and one associated with an atypical form of the disease. These mutations, all situated in the exons or immediately flanking intronic sequences, comprise in-frame insertions and deletions, as well as missense, nonsense, and putative splice-site mutations. Furthermore, we confirmed the putative splice-site mutations we have reported to date (five novel and two previously reported) by isolation of RNA from the affected carriers and characterization of the resultant transcripts using RT-PCR. Since the cloning of CTNS, we have screened for mutations in 108 affected individuals, which has resulted in a high mutation detection rate of 95.8%. Interestingly, the few undetectable mono- or bi-allelic mutations segregated mostly in the noninfantile forms, suggesting that these individuals carry mutations either in the introns or in unidentified regulatory sequences.
Copyright 2002 Wiley-Liss, Inc.
Similar articles
- Molecular pathogenesis of cystinosis: effect of CTNS mutations on the transport activity and subcellular localization of cystinosin.Kalatzis V, Nevo N, Cherqui S, Gasnier B, Antignac C.Kalatzis V, et al.Hum Mol Genet. 2004 Jul 1;13(13):1361-71. doi: 10.1093/hmg/ddh152. Epub 2004 May 5.Hum Mol Genet. 2004.PMID:15128704
- CTNS mutations in patients with cystinosis.Anikster Y, Shotelersuk V, Gahl WA.Anikster Y, et al.Hum Mutat. 1999;14(6):454-8. doi: 10.1002/(SICI)1098-1004(199912)14:6<454::AID-HUMU2>3.0.CO;2-H.Hum Mutat. 1999.PMID:10571941Review.
- Analysis of the CTNS gene in patients of German and Swiss origin with nephropathic cystinosis.Kiehntopf M, Schickel J, Gönne Bv, Koch HG, Superti-Furga A, Steinmann B, Deufel T, Harms E.Kiehntopf M, et al.Hum Mutat. 2002 Sep;20(3):237. doi: 10.1002/humu.9063.Hum Mutat. 2002.PMID:12204010
- Characterization of CTNS mutations in Arab patients with cystinosis.Aldahmesh MA, Humeidan A, Almojalli HA, Khan AO, Rajab M, AL-Abbad AA, Meyer BF, Alkuraya FS.Aldahmesh MA, et al.Ophthalmic Genet. 2009 Dec;30(4):185-9. doi: 10.3109/13816810903200953.Ophthalmic Genet. 2009.PMID:19852576
- [From gene to disease: cystinosis].Levtchenko EN, Wilmer M, de Graaf-Hess AC, van den Heuvel LP, Blom H, Monnens LA.Levtchenko EN, et al.Ned Tijdschr Geneeskd. 2004 Mar 6;148(10):476-8.Ned Tijdschr Geneeskd. 2004.PMID:15042893Review.Dutch.
Cited by
- ClinGen guidance for use of the PP1/BS4 co-segregation and PP4 phenotype specificity criteria for sequence variant pathogenicity classification.Biesecker LG, Byrne AB, Harrison SM, Pesaran T, Schäffer AA, Shirts BH, Tavtigian SV, Rehm HL; ClinGen Sequence Variant Interpretation Working Group.Biesecker LG, et al.Am J Hum Genet. 2024 Jan 4;111(1):24-38. doi: 10.1016/j.ajhg.2023.11.009. Epub 2023 Dec 15.Am J Hum Genet. 2024.PMID:38103548Free PMC article.
- Analysis of CTNS gene transcripts in nephropathic cystinosis.Taranta A, Wilmer MJ, van den Heuvel LP, Bencivenga P, Bellomo F, Levtchenko EN, Emma F.Taranta A, et al.Pediatr Nephrol. 2010 Jul;25(7):1263-7. doi: 10.1007/s00467-010-1502-5. Epub 2010 Mar 30.Pediatr Nephrol. 2010.PMID:20352457Free PMC article.
- Slow progression of renal failure in a child with infantile cystinosis.Bitsori M, Vergadi E, Galanakis E.Bitsori M, et al.CEN Case Rep. 2018 May;7(1):153-157. doi: 10.1007/s13730-018-0316-3. Epub 2018 Feb 14.CEN Case Rep. 2018.PMID:29446030Free PMC article.
- Rab38 modulates proteinuria in model of hypertension-associated renal disease.Rangel-Filho A, Lazar J, Moreno C, Geurts A, Jacob HJ.Rangel-Filho A, et al.J Am Soc Nephrol. 2013 Feb;24(2):283-92. doi: 10.1681/ASN.2012090927. Epub 2013 Jan 4.J Am Soc Nephrol. 2013.PMID:23291471Free PMC article.
- Evaluation of topical cysteamine therapy in the CTNS(-/-) knockout mouse using in vivo confocal microscopy.Simpson JL, Nien CJ, Flynn KJ, Jester JV.Simpson JL, et al.Mol Vis. 2011;17:2649-54. Epub 2011 Oct 8.Mol Vis. 2011.PMID:22065917Free PMC article.
Publication types
MeSH terms
Substances
Related information
LinkOut - more resources
Full Text Sources
Molecular Biology Databases